Merck & Co., Inc. Tax Adjustments, Settlements, and Unusual Provisions
Merck & Co., Inc. (MRK) reported Tax Adjustments, Settlements, and Unusual Provisions of $88.00 million for the 9-month period ending 2017-09-30, per its 10-Q filed 2018-11-06.
Discontinued › Notes › Income Taxes
us-gaap:TaxAdjustmentsSettlementsAndUnusualProvisions · last filed 2018-11-06
- Merck & Co., Inc. tax adjustments, settlements, and unusual provisions for the quarter ending 2017-09-30 was $176.00M.
- Merck & Co., Inc. tax adjustments, settlements, and unusual provisions for the quarter ending 2017-06-30 was -$88.00M.
| Period end | Tax Adjustments, Settlements, and Unusual Provisions 3 month | Tax Adjustments, Settlements, and Unusual Provisions 6 month | Tax Adjustments, Settlements, and Unusual Provisions 9 month | Tax Adjustments, Settlements, and Unusual Provisions 9 month as first filed |
|---|---|---|---|---|
| 2017-09-30 | $176.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $88.00M derived: sum of 2 quarters · filed 2018-11-06 | $88.00M 10-Q · filed 2018-11-06 | -$88.00M 10-Q · filed 2017-11-07 |
| 2017-06-30 | -$88.00M 10-Q · filed 2018-08-07 | -$88.00M 10-Q · filed 2018-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |